Non-adherence in difficult asthma: Time to take it seriously

Thorax

Volumn 67, Issue 3, 2012, Pages 268-270

  Heaney, Liam G ^a   Horne, Rob ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; BRONCHODILATING AGENT; CORTICOSTEROID; HYDROCORTISONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; OMALIZUMAB; PREDNISOLONE; STEROID; THEOPHYLLINE;

ASTHMA; BIOLOGICAL THERAPY; CLINICAL ASSESSMENT; DISEASE CONTROL; DISEASE COURSE; DISEASE MARKER; DRUG MEGADOSE; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HUMAN; MAINTENANCE THERAPY; MEDICAL SPECIALIST; NOTE; PATIENT COMPLIANCE; PATIENT REFERRAL; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT REFUSAL; TREATMENT RESPONSE;

EID: 84857440098     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2011-200257     Document Type: Article

References (24)

1. Masoli M, Fabian D, Holt S, et al Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469-78. (Pubitemid 38580764)
2. World Health Organization. Asthma. Geneva: World Health Organization. http://www.who.int/topics/asthma/en/.
3. Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J 1998;12:1209-18. (Pubitemid 28545638)
4. Anon. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000;162:2341-51.
5. Royal Pharmaceutical Society of Great Britain. From Compliance to Concordance; Achieving Shared Goals in Medicine Taking. London: Royal Pharmaceutical Society of Great Britain and Merck Sharp & Dohme, 1997.
6. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006;130(Suppl 1):65Se72.
7. Gamble J, Stevenson M, McClean E, et al. The prevalence of non-adherence in difficult asthma. Am J Respir Crit Care Med 2009;180:817-22.
8. Murphy AC, Proeschel A, Linnett ME, et al. Identifying non-adherence with asthma medication and the relationship to clinical outcomes amongst adults with difficult-to-control asthma. European Academy of Allergy and Clinical Immunology, 2010;65 (Suppl IV):xlii.
9. Bracken M, Fleming L, Hall P, et al. The importance of nurse-led home visits in the assessment of children with problematic asthma. Arch Dis Child 2009;94:780-4.
10. Robinson DS, Campbell DA, Durham SR, et al Asthma and Allergy Research Group of the National Heart and Lung Institute. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003;22:478-83. (Pubitemid 37098929)
11. O'Neill C, Gamble J, Lindsay JT, et al. The impact of non-adherence to inhaled long-acting b2-agonist/steroid combination therapy on healthcare costs in difficult to treat asthma. Pharmaceut Med 2011. under review.
12. Bousquet J, Mantzouranis E, Cruz AA, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization consultation on severe asthma. J Allergy Clin Immunol 2010;126:926-38.
13. National Institute for Health and Clinical Excellence. Asthma (uncontrolled): omalizumab. London: National Institute for Health and Clinical Excellence. http://guidance.nice.org.uk/TA133.
14. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008;(2):CD000011.
15. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health 2002;17:17-32.
16. Clatworthy J, Price D, Ryan D, et al. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J 2009;18:300-5.
17. Menckeberg TT, Bouvy ML, Bracke M, et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res 2007;64:47-54.
18. Gamble J, Stevenson M, Heaney LG. A study of a multi-level intervention to improve non-adherence in difficult to control asthma. Respir Med. 2011 Apr 19. [Epub ahead of print]. doi:10.1016/j.rmed.2011.03.019
19. Horne R, Kellar I. Chapter 6: Interventions to facilitate adherence. In: Horne R, Weinman J, Barber N, et al. eds. Concordance, Adherence and Compliance in Medicine Taking: A Conceptual Map and Research Priorities. London: National Institute for Health Research (NIHR) Service Delivery and Organisation (SDO) Programme. http://www.sdo.nihr.ac.uk/files/project/SDO-FR-08-1412-076-V01.pdf (accessed 2011)
20. National Institute for Health and Clinical Excellence (NICE). Medicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting Adherence (CG76): Quick Reference Guide. http://guidance.nice.org.uk/ CG76 (accessed January 2009).
21. Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009;180:388-95.
22. Holgate S, Bisgaard H, Bjermer L, et al. The Brussels declaration: the need for change in asthma management. Eur Respir J2008;32:1433-42.
23. Global Initiative for Asthma (GINA).Global Strategy for Asthma Management and Prevention. 2010 http://www.ginasthma.org.
24. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2008;63(Suppl 4):iv1-121.